C07D 277/58
Nitro radicals
C07D277/58 (Nitro radicals) appears on 76 US grants and 45 published applications in this corpus.
Search patents in C07D- Granted patents
- 76
- Published applications
- 45
- Assignees
- 44
- Inventors
- 247
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 2 |
| 2003 | 3 | 1 |
| 2004 | 0 | 4 |
| 2005 | 2 | 3 |
| 2006 | 3 | 3 |
| 2007 | 2 | 3 |
| 2008 | 1 | 0 |
| 2009 | 0 | 5 |
| 2010 | 2 | 2 |
| 2011 | 3 | 1 |
| 2012 | 3 | 3 |
| 2013 | 3 | 1 |
| 2014 | 3 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 2 |
| 2018 | 2 | 0 |
| 2019 | 2 | 2 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 3 |
| 2024 | 0 | 3 |
| 2025 | 2 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of glutathione s-transferases (GSTs) and NAD(P)H:quinone oxidoreductase 1 (NQO1), pharmaceutical compositions, and uses in managing cancer25 Nov 2025US 12,478,614 B2Emory University
- Pharmaceutical composition comprising tizoxanide and pharmaceutical use thereof5 Aug 2025US 12,378,210 B2Beijing Junke Huayuan Med Tech Co., Ltd.
- Compound used as autophagy regulator, and preparation method therefor and uses thereof3 May 2022US 11,319,303 B2Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof3 Mar 2020US 10,577,337 B2Romark Laboratories L.C.
- Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof23 Jul 2019US 10,358,428 B2Romark Laboratories L.C.
- Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer29 Jan 2026US 2026/0027088 A1Emory University
- An improved process for the preparation of nitazoxanide and intermediates thereof19 Dec 2024US 2024/0417381 A1Council of Scientific and Industrial Research An Indian Registered Body Incorporated
- Nitrothiazole derivative and application thereof12 Sep 2024US 2024/0300910 A1Chengdu Biobel Biotechnology Co., Ltd
- Small Molecule Inhibitors of SARS-CoV-2 Infections4 Jan 2024US 2024/0002332 A1
- Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine28 Sep 2023US 2023/0303504 A1Romark Laboratories L.C.
Most cited
By later US patents
- New derivatives of 2-benzamido-5-nitro thiazoles76US 3,950,351 AS.P.R.L. Phavic · 1976
- Urea- and thiourea-type compounds61US 5,773,459 ASugen, Inc. · 1998
- Heteroaromatic glucokinase activators47US 6,320,050 B1Hoffmann-La Roche Inc. · 2001
- Benzamide derivatives40US 5,578,621 A1996
- Heteroaromatic glucokinase activators40US 6,610,846 B1Hoffman-La Roche Inc. · 2003